Alexander Cumbo - 09 Jun 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, Attorney-in-Fact for Alexander Cumbo
Issuer symbol
VERV
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
13 Jun 2022, 17:00:54 UTC
Next filing
05 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Award $0 +31,000 $0.000000 31,000 09 Jun 2022 Common Stock 31,000 $14.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date of the option is the grant date. The shares of common stock underlying the option are scheduled to vest in equal monthly installments through June 9, 2025, subject to the Reporting Person's continued service.